In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1852 News Items found
Pictured: Gabriela Chiosis
Finding
Hsp90: A Very Promising Target for Cancer Therapy

A small molecule discovered at MSK called PU-H71 blocks the growth of cancer cells and enables doctors to image tumors.
Memorial Sloan Kettering is transforming our understanding and treatment of cancer in a myriad of ways.
Feature
Memorial Sloan Kettering Transforms Cancer Research and Care Delivery

Memorial Sloan Kettering’s vision is nothing less than to revolutionize the treatment of cancer. Learn about some of the ways we’re doing it.
Allysia Matthews, with Citymeals-on-Wheels staff donating reusable ice packs
In the Community
Giving Supplies a Second Life, and Making an Environmental Impact in the Process

Memorial Sloan Kettering “green” committees focus on waste reduction and energy efficiency throughout the institution while donating useful supplies to New York–area nonprofits.
Survivors and family members at our Manhattan event signed their names on a wall and wrote messages to staff and other patients.
Event
Olympic Gold Medalist and Cancer Survivor Shannon Miller Addresses Memorial Sloan Kettering Celebration

Olympic gymnast Shannon Miller was diagnosed with germ cell ovarian cancer, a very rare disease, in 2011 and treated at Memorial Sloan Kettering. Learn more about her inspiring story.
Pictured: Gum ball machines
Decoder
What Is Tumor Heterogeneity?

Understanding tumor heterogeneity may be the next big quest in cancer science, as differences between cells within a tumor can have important consequences for how cancers are diagnosed and treated.
Pictured: Serge Lyashchenko
In the Clinic
How Our New Particle Accelerator Will Make Cancer Imaging and Treatment More Precise

The launch of a 20-ton instrument and a facility for producing radioactive imaging molecules will allow our doctors and scientists to monitor cancers in unparalleled detail.
Pictured: Activated macrophage
In the Lab
Researchers Reveal How Tumors Manipulate Certain Immune Cells to Their Own Advantage

Researchers are exploring a mysterious population of immune cells that live within tumors and can help the cancer grow and spread.
Pictured: David Solit
Profile
At Work: Physician-Scientist David Solit

David Solit, Director of the Marie-Josée and Henry R. Kravis Center for Molecular Oncology, discusses how working with cancer patients drives him to develop more-effective, personalized cancer treatments.
Pictured: 2014 Graduates
Event
Memorial Sloan Kettering Celebrates at Convocation and Commencement Ceremony

Degrees were presented and awards were given at the 35th annual ceremony held on May 14.
Pictured: José Baselga, Agnès Viale, Michael Berger & David Solit
Announcement
Bold Initiative to Transform Cancer Care Established with a $100 Million Gift

With the creation of the Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering sets out to deliver on the promise of personalized medicine by creating better treatment options for all people with cancer.